191 related articles for article (PubMed ID: 24144846)
1. The first five years of a preventive programme for haemoglobinopathies in Northeastern Iraq.
Al-Allawi NA; Jalal SD; Ahmed NH; Faraj AH; Shalli A; Hamamy H
J Med Screen; 2013 Dec; 20(4):171-6. PubMed ID: 24144846
[TBL] [Abstract][Full Text] [Related]
2. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme.
Al-Allawi NA; Al-Dousky AA
East Mediterr Health J; 2010 Apr; 16(4):381-5. PubMed ID: 20795420
[TBL] [Abstract][Full Text] [Related]
3. Premarital screening for hemoglobinopathies: experience of a single center in Kurdistan, Iraq.
Al-Allawi NA; Al-Doski AA; Markous RS; Mohamad Amin KA; Eissa AA; Badi AI; Asmaro RR; Hamamy H
Public Health Genomics; 2015; 18(2):97-103. PubMed ID: 25613574
[TBL] [Abstract][Full Text] [Related]
4. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
5. Sociocultural challenges of beta-thalassaemia major birth in carriers of beta-thalassaemia in Iran.
Haghpanah S; Nasirabadi S; Rahimi N; Faramarzi H; Karimi M
J Med Screen; 2012 Sep; 19(3):109-11. PubMed ID: 23093727
[TBL] [Abstract][Full Text] [Related]
6. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme.
Karimi M; Jamalian N; Yarmohammadi H; Askarnejad A; Afrasiabi A; Hashemi A
J Med Screen; 2007; 14(2):62-6. PubMed ID: 17626703
[TBL] [Abstract][Full Text] [Related]
7. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
[TBL] [Abstract][Full Text] [Related]
9. Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
Khoshnaw NSH; Omar JJ; Hussein ZS; Mohammed RN
Hemoglobin; 2024 Jan; 48(1):56-59. PubMed ID: 38565325
[TBL] [Abstract][Full Text] [Related]
10. [A community-based genetic screening of large-scale population and prenatal diagnosis for alpha and beta thalassemia in Zhuhai city of Guangdong province].
Zhou YQ; Mo QH; Lu JH; Li LY; Liang X; Jia SQ; Xiao GF; Zhou WJ; Xiao QZ; Xu XM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):256-61. PubMed ID: 18543211
[TBL] [Abstract][Full Text] [Related]
11. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.
Voskaridou E; Ladis V; Kattamis A; Hassapopoulou E; Economou M; Kourakli A; Maragkos K; Kontogianni K; Lafioniatis S; Vrettou E; Koutsouka F; Papadakis A; Mihos A; Eftihiadis E; Farmaki K; Papageorgiou O; Tapaki G; Maili P; Theohari M; Drosou M; Kartasis Z; Aggelaki M; Basileiadi A; Adamopoulos I; Lafiatis I; Galanopoulos A; Xanthopoulidis G; Dimitriadou E; Mprimi A; Stamatopoulou M; Haile ED; Tsironi M; Anastasiadis A; Kalmanti M; Papadopoulou M; Panori E; Dimoxenou P; Tsirka A; Georgakopoulos D; Drandrakis P; Dionisopoulou D; Ntalamaga A; Davros I; Karagiorga M;
Ann Hematol; 2012 Sep; 91(9):1451-8. PubMed ID: 22526366
[TBL] [Abstract][Full Text] [Related]
12. Neonatal haemoglobinopathy screening in Belgium.
Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
[TBL] [Abstract][Full Text] [Related]
13. Prevention of thalassaemia and haemoglobinopathies in remote and isolated communities--the Maldives experience.
Firdous N
Ann Hum Biol; 2005; 32(2):131-7. PubMed ID: 16096208
[TBL] [Abstract][Full Text] [Related]
14. Control and prevention of the genetic load of haemoglobinopathies in India.
Balgir RS
Natl Med J India; 1999; 12(5):234-8. PubMed ID: 10613007
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
Belhoul KM; Abdulrahman M; Alraei RF
Hemoglobin; 2013; 37(4):359-68. PubMed ID: 23647352
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Effectiveness of Mandatory Premarital Screening and Genetic Counselling Programmes for β-Thalassaemia in the Middle East: A Scoping Review.
Saffi M; Howard N
Public Health Genomics; 2015; 18(4):193-203. PubMed ID: 26045079
[TBL] [Abstract][Full Text] [Related]
17. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra.
Hassan MK; Taha JY; Al-Naama LM; Widad NM; Jasim SN
East Mediterr Health J; 2003; 9(1-2):45-54. PubMed ID: 15562732
[TBL] [Abstract][Full Text] [Related]
18. Outcome of a school screening programme for carriers of haemoglobin disease.
Lena-Russo D; Badens C; Aubinaud M; Merono F; Paolasso C; Martini N; Mattei JF
J Med Screen; 2002; 9(2):67-9. PubMed ID: 12133925
[TBL] [Abstract][Full Text] [Related]
19. [Hemoglobinopathy in the county of Copenhagen].
Birgens HS; Karle H; Guldberg P; Güttler F
Ugeskr Laeger; 1997 Jun; 159(25):3934-9. PubMed ID: 9214066
[TBL] [Abstract][Full Text] [Related]
20. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation.
Ladis V; Karagiorga-Lagana M; Tsatra I; Chouliaras G
Eur J Haematol; 2013 Apr; 90(4):313-22. PubMed ID: 23331260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
